ProfileGDS4177 / 234864_s_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 46% 42% 51% 69% 43% 43% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated28.8146
GSM603099KU-812 non-treated23.2742
GSM603098KCL-22 Imatinib-treated33.8551
GSM603097KCL-22 non-treated92.5969
GSM603102JURL-MK1 Imatinib-treated24.6143
GSM603101JURL-MK1 non-treated24.943